Equites Radar

ALB · Albemarle Corporation

Specialty ChemicalsUnited StatesAnalyst view: Buy

$117.52

-3.44% last session

End-of-day data · close of 2026-09-11

Bearish0 bullish · 4 bearish technical signals
Consensus: Buy (1.95 from 20 analysts)
To mean target: +41.3%

Market cap

$14B

Enterprise value

$17B

Trailing P/E

435.3

Forward P/E

10.4

Dividend yield

1.0%

Beta

1.33

Avg volume

2M

Employees

8K

Daily Change %

-3.44%

5 Days Change

-3.30%

10 Days Change

-9.91%

30 Days Change

-4.85%

60 Days Change

-2.93%

Month to Day Change

-9.91%

Year to Day Change

-13.23%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.95
Covering analysts20
Mean price target$172.56
Low price target$83.28
Upside to mean target+41.3%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)35.3
50-day MA$126.77
200-day MA$155.67
Price vs 50-day MA-7.3%
Price vs 200-day MA-24.5%
MACD histogram-1.99
Volume vs 3-month avg1.0×
52w low $73.8052w high $214.35

Analyst sentiment over time — ALB

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-25

Latest call per bank · past 12 months

JP Morgan

Neutral

$140

+14.7% vs price
▼ cut from $160Maintains · 2026-08-25

RBC Capital

Outperform

$157

+28.6% vs price
▼ cut from $166Maintains · 2026-08-10

Morgan Stanley

Equal-Weight

$161

+31.8% vs price
▼ cut from $189Maintains · 2026-08-10

UBS

Buy

$175

+43.3% vs price
▼ cut from $205Maintains · 2026-08-07

Citigroup

Buy

$175

+43.3% vs price
▼ cut from $225Maintains · 2026-08-07

Bank of America

Buy

$155

+26.9% vs price
Reiterates · 2026-08-07

Wells Fargo

Equal-Weight

$200

+63.8% vs price
Reiterates · 2026-06-04

Deutsche Bank

Buy

$250

+104.7% vs price
▲ raised from $210Maintains · 2026-05-13

Jefferies

Buy

$230

+88.4% vs price
▲ raised from $210Maintains · 2026-01-28

Recent rating actions

DateFirmActionRatingPrice target
2026-08-25JP MorganMaintainsNeutral$160 $140
2026-08-10RBC CapitalMaintainsOutperform$166 $157
2026-08-10ScotiabankMaintainsSector Outperform$200 $190
2026-08-10Evercore ISI GroupMaintainsIn-Line$180
2026-08-10Morgan StanleyMaintainsEqual-Weight$189 $161
2026-08-07UBSMaintainsBuy$205 $175
2026-08-07CitigroupMaintainsBuy$225 $175
2026-08-07Truist SecuritiesMaintainsBuy$245 $225

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 35 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 7.3% below the 50-day MA ($126.77).
  • Price vs 200-day MA: Trading 24.5% below the 200-day MA ($155.67).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-1.99) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($73.80) and high ($214.35).

ALB Price Chart

Loading chart for ALB

Fundamentals

Revenue (TTM)$6.0B
EBITDA$1.0B
Free cash flow$1.0B
Operating cash flow$2.0B
Book value / share$68.14
Net Debt / EBITDA0.3
WACC12.0%
Revenue growth31.00%
Earnings growth

About Albemarle Corporation

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

More in Specialty Chemicals

Screen ALB against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.